Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines

References

• Naldi I, Taranta M, Gherardin L, et al. Novel epigenetic target therapy for prostate cancer: a preclinical study. PLoS One. 2014;9:98–101.
   Web of Science ®Google Scholar
• Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011;29:323–332.
   PubMed Web of Science ®Google Scholar
• Poustchi H, Sepanlou SG, Esmaili S, et al. Hepatocellular carcinoma in the world and the Middle East. Middle East J Dig Dis. 2010;2:31–41.
   PubMedGoogle Scholar
• Jinsil S. Challenge and hope in radiotherapy of hepatocellular carcinoma. Yonsei Med J. 2009;50:601–612.
   PubMed Web of Science ®Google Scholar
• Yanan S, Jing S, Geyi L, et al. Advances of blood cell-based drug delivery systems. Eur J Pharm Sci. 2017;96:115–128.
   PubMed Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y. Nanoparticles – a review. Trop J Pharm Res. 2006;5:561–573.
   Google Scholar
• Chandran SP, Natarajan SB, Chandraseharan S, et al. Nano drug delivery strategy of 5-fluorouracil for the treatment of colorectal cancer. JCRPR. 2017;4:45–48.
   Google Scholar
• Li W, Zhang L, Zhang G, et al. The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy. Mini Rev Med Chem. 2013;13:643–652.
   PubMed Web of Science ®Google Scholar
• Brian T, Luk LZ. Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release. 2015;220:600–607.
   PubMed Web of Science ®Google Scholar
• Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6:287–296.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 2011;108:10980–10985.
   PubMed Web of Science ®Google Scholar
• Noble GT, Stefanick JF, Ashley JD, et al. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol. 2014;32:32–45.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CMJ, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14:2181–2188.
   PubMed Web of Science ®Google Scholar
• Lu M, Zhao X, Xing H, et al. Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: implications for therapeutic delivery. Acta Biomater. 2018;76:1–20.
   PubMed Web of Science ®Google Scholar
• Gopal VS, Ranjith KA, Usha AN, et al. Effective drug targeting by erythrocytes as carrier systems. Curr Trends Biotechnol Pharm. 2007;1:18–33.
   Google Scholar
• Harisa GI, Ibrahim MF, Alanazi F, et al. Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel. Saudi Pharm J. 2014;22:223–230.
   PubMed Web of Science ®Google Scholar
• Rossi L, Serafini S, Pierige F, et al. 2005. Erythrocyte-based delivery. Exp Opin Deliv. 2:311–322.
   PubMedGoogle Scholar
• Harisa GI, Badran MM, AlQahtani SA, et al. Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi Pharm J. 2016;24:74–81.
   PubMed Web of Science ®Google Scholar
• Gustafson HH, Casper DH, Grainger DW, et al. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10:487–510.
   PubMed Web of Science ®Google Scholar
• Alanazi FK, Yassin AE, El-Badry M, et al. Validated high-performance liquid chromatographic technique for determination of 5-fluorouracil: applications to stability studies and simulated colonic media. J Chromatogr Sci. 2009;47:558–563.
   PubMed Web of Science ®Google Scholar
• Liko F, Suna E, Özer YA, et al. In vitro studies on 5-florouracil-loaded DTPA-PE containing nanosized pegylated liposomes for diagnosis and treatment of tumor. J Liposome Res. 2013;23:61–69.
   PubMed Web of Science ®Google Scholar
• Singh V, Krishan P, Shri R. Amelioration of ischaemia reperfusion-induced cerebral injury in mice by liposomes containing Allium cepa fraction administered intranasally. Artif Cells Nanomed Biotechnol. 2018;19:1-11..
   Web of Science ®Google Scholar
• Dong X, Niu Y, Ding Y, et al. Formulation and drug loading features of nano-erythrocytes. Nanoscale Res Lett. 2017;12:202.
   PubMed Web of Science ®Google Scholar
• Gupta N, Patel B, Ahsan F. Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization. Pharm Res. 2014;31:1553–1565.
   PubMed Web of Science ®Google Scholar
• Kostić IT, Ilić VLJ, Đorđević VB, et al. Erythrocyte membranes from slaughterhouse blood as potential drug vehicles: isolation by gradual hypotonic hemolysis and biochemical and morphological characterization. Colloids Surf B Biointerfaces. 2014;122:250–259.
   PubMed Web of Science ®Google Scholar
• Badran MM, Mohsen MM, Magdy MG, et al. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer. Inter J Biol Macromol. 2017;95:643–649.
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang K, Zhou Z, et al. Erythrocyte membrane nanoparticles improve the intestinal absorption of paclitaxel. Biochem Biophys Res Commun. 2017;488:322–328.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Chen W, et al. Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release. 2017;263:185–191.
   PubMed Web of Science ®Google Scholar
• Silva DC, Jovino CN, Silva CA, et al. Optical tweezers as a new biomedical tool to measure zeta potential of stored red blood cells. PLoS One. 2012;7:e31778
   PubMed Web of Science ®Google Scholar
• Alanazi FK, Harisa G-D, Maqboul A, et al. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study. Arch Pharm Res. 2011;34:563–571.
   PubMed Web of Science ®Google Scholar
• Luk BT, Hu CMJ, Fang RH, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 2013;6:2730–2737.
   Web of Science ®Google Scholar
• Rao L, Bu LL, Xu JH, et al. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance. Small. 2015;11:6225–6236.
   PubMed Web of Science ®Google Scholar